Description
White Balance Cream is formulated to lighten dark spots and balance uneven skin tone by reducing melanin production in the skin. It typically contains skin-friendly brightening agents such as niacinamide, alpha arbutin, kojic acid, vitamin C, or licorice extract, which work together to fade pigmentation while improving overall skin clarity.
Primary Uses
-
Lightening dark spots, acne marks, and sun damage.
-
Reducing melasma or pregnancy-related pigmentation.
-
Evening out dull or uneven skin tone.
-
Improving overall brightness and skin texture.
How It Works
White Balance Cream slows down melanin formation — the pigment responsible for skin darkening — while promoting cell turnover to reveal fresher, brighter skin. With regular use, it helps fade discoloration and prevents new spots from forming.
Side Effects
Generally well-tolerated but mild irritation may occur in sensitive individuals.
Possible reactions:
-
Redness.
-
Mild itching or dryness.
-
Sensitivity to sunlight.
Warnings
-
Always apply sunscreen during daytime while using brightening products.
-
Avoid broken or irritated skin.
-
Patch test recommended before full-face application.
Contraindications
Not recommended for individuals with:
-
Allergy to any brightening ingredients (like kojic acid, arbutin, or vitamin C derivatives).
-
Active eczema, psoriasis, or severe skin inflammation.
How to Use
-
Apply a small amount to cleansed skin.
-
Use once or twice daily (preferably at night).
-
Follow with sunscreen in the morning.
Doctor’s Review
Dr. Rabia Hussain (Dermatologist):
“White Balance Cream is useful for mild to moderate pigmentation when used consistently with sun protection. It doesn’t bleach the skin but gradually improves tone and brightness. Patience is key — visible results usually appear in 4–6 weeks.”
Disclaimer
This profile is for information only and not a medical prescription. Always consult a dermatologist before starting any new skincare treatment, especially if you have sensitive or allergy-prone skin.
Reviews
There are no reviews yet.